Skip to main content
. 2019 Oct-Dec;15(4):267–273. doi: 10.14797/mdcj-15-4-267

Table 1.

Strategies to reduce anthracycline-induced chemotherapy.9

CARDIOPROTECTIVE STRATEGY
Limit cumulative dose (mg/m2)

  • Daunorubicin < 800

  • Doxorubicin < 360

  • Epirubicin < 720

  • Mitoxantrone < 160

  • Idarubicin < 150

Alter administration (continuous infusion)
Use fewer cardiotoxic anthracycline analogues (epirubicin, idarubicin, and mitoxantrone)
Choose lipossomal formulations
Administer cardioprotective drugs (discussed in “Prevention” section)